
Healthcare · NSE
Nephro Care India Limited, incorporated in 2014 and based in Kolkata, is a specialized treatment center focusing on renal insufficiency and comprehensive clinical and lifestyle solutions. Supported by expert doctors, paramedical professionals, and a skilled management team, the hospital serves approximately 900 Chronic Kidney Disease patients monthly. Operating from a 5,352 sq. ft. main clinic in Salt Lake and three satellite clinics in Salt Lake (HB 113) and Chandannagar, West Bengal, Nephro Care employs 110 staff members, including 5 permanent doctors, 10 visiting consultants, and 70 paramedical professionals. The center offers a wide range of services, including an in-house Dialysis Unit, outpatient services in nephrology, diabetology, cardiology, ophthalmology, and neurology, an NABL-accredited in-house pathology, a pharmacy, advanced diagnostics, a renal nutrition department, home care, the Mukti Lifestyle Support Program, and home dialysis services.
Price Band
₹85 – ₹90
Issue Size
₹41.26 Cr
Lot Size
1600 shares
GMP
+194.4%
Est. Listing
₹265
at current GMP
Subscribed
770.15x
overall
Open
28 Jun 2024
Close
2 Jul 2024
Allotment
3 Jul 2024
Refund
4 Jul 2024
Demat Credit
5 Jul 2024
Listing
5 Jul 2024
Designated Registrar: Bigshare Services Private Limited
Allotment Date
3 Jul 2024
Basis finalization
Refunds Initiate
4 Jul 2024
Mandate release
Demat Credit
5 Jul 2024
Shares in demat
Listing Debut
5 Jul 2024
Trading begins
Nephro Care India Limited is bringing an initial public offering (IPO) in the Healthcare sector with an aggregate issue size of ₹41.26 Crores. The shares are offered at a price band of ₹85 to ₹90 per equity share on NSE. Currently, investors are tracking the grey market premium (GMP) and institutional subscription multiples closely across BSE and NSE portals.
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Following the close of bidding on 2024-07-02, the basis of allotment is scheduled to be finalized on 2024-07-03. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Bigshare Services Private Limited) or the BSE allotment checking window.
Allotment records are updated in batches. If the status is not yet available, please wait a few hours until the basis of allotment is fully finalized.
Since funds are blocked under ASBA/UPI, the bank will automatically release the blocked hold on your funds upon receipt of revocation instructions from the sponsor bank.